Men undergoing radical cystectomy are most likely to recover erectile function if they have good function before the surgery and receive nerve-sparing, according to investigators.
Longer follow-up from the CheckMate 274 trial shows nivolumab given after radical surgery for high-risk muscle-invasive urothelial carcinoma maintains a clinically meaningful improvement in disease-free survival.
Although most men with low-risk prostate cancer are now managed initially with active surveillance, use of this approach remains suboptimal, according to investigators.
Positive surgical margins in patients undergoing robotic partial nephrectomy for renal tumors are associated with adverse oncologic outcomes, a study revealed.
An interim analysis suggests that axitinib given to patients with complex clear cell renal cell carcinoma tumors significantly reduces tumor size and complexity.